NCT07125157 Effect Of Task-Specific Training With And Without Biofeedback On Balance And Risk Of Falls In Chronic Ischemic Stroke Patients Of Central Lahore, Pakistan
| NCT ID | NCT07125157 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Syed Ali Behram Subazwari |
| Condition | Chronic Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2026-03-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2026-02-10 with a primary completion date of 2026-03-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effects of task-specific training with and without biofeedback compared to conventional physical therapy on balance and fall risk in chronic ischemic stroke patients in Lahore, Pakistan. Sixty-six participants will be randomly allocated into three groups: Group 1 (task-specific training with biofeedback), Group 2 (task-specific training without biofeedback), and Group 3 (conventional physical therapy). The intervention will span 12 weeks, consisting of 36 sessions. Key outcome measures include the Berg Balance Scale, Timed Up and Go Test, and the Barthel Index. Assessments will be conducted at baseline, post-intervention, and three-month follow-up. The study hypothesizes that the use of biofeedback in task-specific training will produce significantly greater improvements in balance and reduced fall risk compared to conventional rehabilitation strategies. The study is being conducted at Shadman Medical Center in Lahore and is part of a PhD project from Lincoln University College.
Eligibility Criteria
Inclusion Criteria: Chronic ischemic stroke patients (more than 3 months after stroke) Both Male and Female Patients Patients of 40 or above years of age Patients with Burnstorm stage 3 or above.) Patients with good cognitive function (score of 20 or more on MMSE) Patients who can ambulate 10 m (with or without the assistive device) Exclusion Criteria: Patients undergoing concurrent therapy or treatment that could influence the effectiveness of this study will be excluded from participation Patients presenting with contraindications to rehabilitation, such as severe uncontrolled hypertension, uncontrolled diabetes, or unstable angina, will be excluded from the study. Individuals with prior neurological impairments apart from stroke.
Contact & Investigator
Syed Ali Behram Subazwari, Phd physiotherapy
PRINCIPAL INVESTIGATOR
Lincoln University College Malaysia
Frequently Asked Questions
Who can join the NCT07125157 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Chronic Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07125157 currently recruiting?
Yes, NCT07125157 is actively recruiting participants. Contact the research team at subazwari@lincoln.edu.my for enrollment information.
Where is the NCT07125157 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07125157 clinical trial?
NCT07125157 is sponsored by Syed Ali Behram Subazwari. The principal investigator is Syed Ali Behram Subazwari, Phd physiotherapy at Lincoln University College Malaysia. The trial plans to enroll 66 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.